- ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules-A Large Study of 2022 Cases in ChinaYang, Xiongwen; Xiao, Yi; Hu, Hao; Qiu, Zhen-Bin; Qi, Yi-Fan; Wang, Meng-Min; Wu, Yi-Long; Zhong, Wen-ZhaoAnnals of Surgical Oncology, 2024, 31(1): 245-246.
- Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancerLi, Huijuan; Lin, Dang*; Lv, Tangfeng*Translational Lung Cancer Research, 2022.
- In-depth genomic characterization of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.Kang, Li; Liu, Jun; Li, Jia; Wu, Lin; Xiao, Yajie; Du, Haijian; Zhao, Zhikun; Li, Xiaoting; Wu, Dongfang; Zhao, Zhuxiang; Chen, BolinVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2021-06-04 To 2021-06-08.
期刊论文
ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma
23阅读
